Recently, studies found that YKL-40 has an important role in several autoimmune diseases such as systemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis, Behçet disease, and inflammatory bowel disease. Here, CHI3L1 is linked to systemic sclerosis.